Podcasts about stage iii

In celebration of Pride Month, each Friday in June we're re-sharing our favorite episodes featuring LGBTQ+ voices from the Wildfire community.Stephanie Millett was first diagnosed with Stage III breast cancer at 25, and again at 31 with Stage IV MBC. Stephanie is a retired hairstylist, writer, and advocate for advancedbreastcancer.net. In this episode, Stephanie shares their essay, “My Life, and Being Wrong,” from Wildfire Journal's 2022 Legacy Stories issue. Stephanie and April discuss the power of sharing your story through advocacy, the reasons some people choose privacy around their cancer experience, and what it means to model resilience and honesty for our children. They also talk about Stephanie's future plans to write a book offering practical guidance for others who want to begin telling their own stories.More about Stephanie: https://www.instagram.com/_the_radiatedlizard/ Listen to Stephanie on another episode on The Burn: https://player.captivate.fm/episode/bf5a9ce5-4858-43b1-88ff-d4b00cb8623c/Shop Wildfire for merch & more: https://www.wildfirecommunity.org/shop/p/queerincancerland24Buy the Wildfire book Igniting the Fire Within: Stories of Healing, Hope & Humor, Inside Today's Young Breast Cancer Community: https://www.amazon.com/dp/B0BJVJ629F?ref_=pe_3052080_397514860Get the free Wildfire “Hot Flashes” email newsletter: https://www.wildfirecommunity.org/newsletter?rq=newsletterLearn about Wildfire writing workshops: https://www.wildfirecommunity.org/workshopsShop Wildfire merch & more: https://www.wildfirecommunity.org/shop*Free* Get Wildfire and The Burn freebies here: https://www.wildfirecommunity.org/freeMore about Wildfire Journal: https://www.wildfirecommunity.orghttps://www.instagram.com/wildfire_bc_magazine/https://www.facebook.com/wildfirecommunityInformation on submitting your story for consideration to be published in Wildfire Journal: https://www.wildfirecommunity.org/submissions

General Principles and Triple AssessmentThe foundation of breast cancer diagnosis is the Triple Assessment protocol, which includes clinical examination, imaging, and pathological assessment.Diagnostic accuracy reaches 99.9% when all three modalities of the Triple Assessment align.Imaging choices are age-dependent, with ultrasound preferred for women under 35 and mammography for those over 35.Core needle biopsy is superior to fine-needle aspiration because it differentiates between in situ and invasive disease and allows for hormone receptor and HER2 status testing.The majority of breast cancers are sporadic, accounting for 65% to 75% of cases, while hereditary factors like BRCA 1 and 2 mutations contribute to 5% to 10%.Classification and Clinical PresentationBreast cancer is classified into non-invasive types, such as Ductal Carcinoma In Situ (DCIS), and invasive types, of which invasive ductal carcinoma is the most common.The most frequent clinical presentation is a hard, irregular, non-tender, and poorly mobile palpable mass.Approximately 60% of breast tumors are located in the upper outer quadrant.Advanced clinical features include skin dimpling from Cooper's ligament involvement, nipple retraction, and peau d'orange due to lymphatic obstruction.Paget's disease of the nipple presents as a unilateral, eczema-like ulceration and is often associated with an underlying malignancy.Staging and PrognosisClinical staging follows the TNM system, assessing the primary tumor size (T), regional lymph node involvement (N), and distant metastasis (M).Stage I and II are classified as early breast cancer, Stage III as locally advanced, and Stage IV as metastatic disease.The Nottingham Prognostic Index (NPI) calculates prognosis based on tumor size, nodal status, and histological grade.Five-year survival rates decrease significantly with advancing stage, from 90% in Stage I to 20% in Stage IV.Management of DCIS and Early Breast Cancer (Stages I & II)DCIS is a non-invasive cancer confined by an intact basement membrane that requires treatment to prevent progression to invasive disease.Standard treatment for DCIS is breast-conserving surgery (BCS) followed by radiation, or a mastectomy if the disease is widespread.For early invasive cancer, BCS followed by radiation is oncologically equivalent to a total mastectomy.Sentinel lymph node biopsy (SLNB) is the standard for staging the axilla in clinically node-negative patients to avoid the morbidity of full axillary dissection.Adjuvant systemic therapy, including endocrine therapy for ER-positive tumors and anti-HER2 therapy for HER2-positive tumors, is dictated by the tumor's biological profile.Management of Locally Advanced (Stage III) and Metastatic Cancer (Stage IV)Locally advanced breast cancer is treated with neoadjuvant systemic therapy as the first step to shrink the tumor and treat micrometastatic disease before surgery.Following neoadjuvant therapy, axillary lymph node dissection is mandatory if nodes were positive at presentation, regardless of the clinical response.Post-mastectomy radiation is indicated for tumors larger than 5 cm or when four or more axillary nodes are positive.Metastatic (Stage IV) disease is treatable but generally incurable, focusing on palliation and maintaining quality of life.Systemic therapy is the mainstay for Stage IV, and routine surgery on the primary tumor is avoided unless needed for local symptom control.Bone is the most common site of metastasis, requiring management with bone-modifying agents like bisphosphonates to prevent skeletal complicatio

What do you do when the only treatment offered isn't working? Chris Joseph, author of Life is a Ride, discusses his remarkable recovery from inoperable stage III pancreatic cancer. After traditional chemotherapy failed and his tumor continued to grow, Chris made the pivotal decision to fire his oncologist and take full command of his health "terrain."Chris shares the multi-faceted approach that led to his survival nearly a decade after his diagnosis. We dive deep into the metabolic approach to cancer, the power of intuition and why healing is never a passive process.Key Information and Time Stamps01:34 Chris recounts his "jarring" diagnosis of stage III inoperable pancreatic cancer. A critical discussion follows on how a doctor's suggestion to "go home and pray" can inadvertently rob a patient of hope07:24 The pivotal moment when Chris quit chemotherapy after his tumor continued to grow. The transition from a passive patient to an active participant and the profound peace that comes with taking responsibility for one's own healing path.12:18 Chris details his three-week intensive in Germany, highlighting integrative medicine, non-Western treatments including Vitamin C infusions, B17, ozone therapy, hyperthermia and dendritic stem cell therapy, to rebuild his immune system ravaged by chemo.16:19 A deep dive into why 90% of cancers are not hereditary. Chris and Sarah discuss environmental toxins, lifestyle choices and chronic stress as controllable factors that offer an opportunity for radical life changes.27:28 Chris shares his daily health stack: using a portable infrared sauna for 90 minutes, adopting a low-carb/keto-leaning diet and the simple but powerful mental filter of asking, "Is this food going to help me or hurt me?"32:49 A fascinating look at the nervous system's role in recovery. Sarah and Chris discuss why they both ditched the Television and how toxic news cycles agitate the body, preventing the relaxation response necessary for deep healing.40:11 Chris provides his top three tips: take charge, trust your intuition and embrace the work. He emphasizes that while healing requires immense effort, the result is a quality of life far superior to his pre-cancer years.Chris' Bio Chris Joseph is a certified Terrain Advocate in the Metabolic Approach to Cancer and a certified Radical Remission Coach. Diagnosed in 2016 with stage 3 inoperable pancreatic cancer, Chris chose to expand beyond conventional protocols and focus on transforming his internal terrain—metabolic, emotional, environmental, and spiritual. Nearly a decade later, he continues to thrive.Through one-on-one coaching, workshops, online communities, and retreats, Chris helps individuals and families take control of their health with clarity and confidence. His approach emphasizes informed choice, personal responsibility, and the understanding that healing is not passive—it requires participation.He is the author of Life is a Ride: My Unconventional Journey of Cancer Recovery.Connect with Chris https://terrainnavigators.com/https://www.facebook.com/chrisjosephInSantaMonicahttps://www.facebook.com/share/g/17GkZCy4ug/https://www.facebook.com/search/top?q=terrain%20navigatorsWho am I?Sarah Dawkins is a passionate Holistic Health and Healing Coach, international speaker and author of Heal Yourself. She's also a multi-award-winning entrepreneur and the award-winning host of the uplifting podcast Mind Body Medicine for Self Healers with Sarah Dawkins.With over 20 years' experience as a Registered Nurse, Sarah combines her deep understanding of conventional medicine with her own powerful self-healing journey to create a truly integrative approach. Having overcome multiple chronic health challenges herself, she now supports others in uncovering and addressing the root causes of their symptoms, helping them restore balance, reclaim their energy and create lasting, vibrant wellness.www.sarahdawkins.com

Featuring perspectives from Dr Stacey A Cohen, Dr Christopher Lieu and Dr Jenny Seligmann, moderated by Dr Lieu, including the following topics: Role of circulating tumor DNA (ctDNA) testing in the escalation of treatment for Stage II and deescalation for Stage III colon cancer (0:00) Impact of timing on the clinical relevance of ctDNA minimal residual disease test results in localized colorectal cancer (8:58) Approach to managing Stage III colon cancer with ctDNA-positive results after adjuvant treatment (13:35) CME information and select publications

On this episode of the Mastery Unleashed Podcast, Christie Ruffino interviews Dr. Neja Zupan, who shares a deeply transformative journey shaped by loss, illness, and personal reinvention. After witnessing her mother pass away from cancer with unfulfilled dreams, Dr. Neja made a commitment to live fully and stop postponing her purpose. Later, she faced her own diagnosis of aggressive cancer with only a 5% survival rate, which became a turning point for profound healing and transformation.Rather than following conventional medical paths alone, Dr. Neja explored a holistic approach, developing what she calls “multidimensional intelligence.” This framework integrates physical, emotional, mental, energetic, and spiritual levels to create alignment, vitality, and sustainable success. She applied these principles not only to heal herself but also to transform her business, allowing it to scale internationally with more ease and flow.Central to her teachings are the “Dragon Laws”: cultivating inner peace, thinking beyond conventional limitations, and viewing challenges as opportunities for growth. These principles empower entrepreneurs to break free from burnout, stress, and traditional hustle-driven models.This episode encourages listeners to trust their intuition, embrace transformation, and align their life and business with a deeper purpose for lasting success and fulfillment. ABOUT DR. NEJADr. Neja Zupan is a Global Energy Master and Founder of the Energy Masters Academy, guiding leaders and change makers to understand that inner energy, not strategy, determines how they lead, decide, and create impact.Through practical, body based work rooted in nervous system recalibration, emotional clearing, and multidimensional intelligence, she helps leaders release hidden stress patterns and shift from pressure into presence. When energy aligns, vitality rises, decisions clarify, and results unfold with less force and more resonance.Her work is grounded in lived truth. After being diagnosed with aggressive Stage III+ cancer and carrying the BRCA gene that had taken multiple women in her family, Dr. Neja chose an inner path of energetic recalibration. Within six months, she was cancer free and fundamentally transformed.Today, she empowers leaders to lead from inner authority, embody coherence, and create sustainable impact as an authentic expression of who they are. GET DR. NEJA'S GENEROUS GIFTThe Dragon Laws: Your Business Beyond Logic ToolkitACCESS THIS GIFT AND MANY MORE LINKS SHARED ON THE SHOWwww.linkedin.com/in/drnejazupan/www.instagram.com/dr.neja.zupan.institutewww.facebook.com/drNejaZupanInstitutewww.tiktok.com/@dr_neja_zupan_instituteABOUT OUR SHOWMastery Unleashed is a podcast for success-driven women who want to empower their thoughts, design their dream businesses, and build beautiful lives that are aligned with their destinies—hosted by Bestselling Author and Business Strategist Christie Ruffino.Each episode features today's top influencers and entrepreneurs on the rise as they share empowering stories and ninja tips meant to become the FUEL that will ignite a positive change in YOUR life and the lives of others.ABOUT OUR FREE GIFT VAULTGET THIS GIFT AND MANY MORE HERE: https://masteryunleashedpodcast.com/gift-signup/

Send us Fan MailPaper Discussed in this Episode:Deep-learning-based breast cancer stage prediction from H&E-stained whole-slide images in resource-constrained settings. Bedőházi Z, Biricz A, Kilim O, et al. Journal of Pathology Informatics 21 (2026) 100644.Episode Summary:Welcome back, Trailblazers! In this Journal Club deep dive of the Digital Pathology Podcast, we flip the core assumption of microscopic precision on its head. Can an AI accurately predict pathological breast cancer stages (pTNM I-III) from a blurry, high-altitude 2.5x magnification snapshot? We explore a 2026 study that strips away standard high-resolution data to build a highly efficient, resource-aware AI diagnostic tool for clinics lacking supercomputers. We unpack the math, the models, and a haunting revelation about what primary tumors can tell us about distant metastasis.In This Episode, We Cover:• The Compute Bottleneck: Why the digital pathology AI revolution is leaving resource-constrained clinics behind, and how dropping from the standard 40x to 2.5x magnification slashes image patch extraction by 256 times, bypassing massive hardware and server requirements.• The "Airplane View": How the AI compensates for the loss of microscopic cellular details (like mitosis or cellular atypia) by relying on macroscopic features, identifying disease through overall tumor growth patterns and broad architectural disruption.• Vision Transformers & "Puzzle Bags": Why the UNI foundation model—a vision transformer fine-tuned on the BRACS dataset—outperforms older convolutional networks (like ResNet-50) by mapping long-range spatial dependencies across the entire image patch simultaneously. Plus, how Multiple Instance Learning (MIL) acts as a targeted "puzzle bag," mathematically weighting critical cancer data and ignoring irrelevant background noise.• The Real-World Stress Test: The model's solid performance on the internal Semmelweis dataset versus the massive external Nightingale cohort, where unsupervised data cleaning with t-SNE and DBSCAN clustering automatically deleted garbage data. We also discuss the AI's struggle with the TCGA-BRCA dataset due to severe domain shift from heterogeneous tissue preparation, specifically the structural tissue damage caused by frozen sections.• The "Messy Middle" and Clinical Triage: The model's tendency to struggle with Stage II breast cancer and the critical clinical danger of under-staging advanced Stage III cancers. We discuss why this WSI-only baseline isn't replacing human pathologists, but rather serves as an automated "sorting hat" for incomplete medical records or a highly tunable "smoke detector" to route suspicious slides for immediate manual review.Key Takeaway:The AI successfully predicted overall cancer stage—which inherently includes distant lymph node metastasis—by looking only at the primary tumor's architectural disruption, without ever evaluating a single lymph node slide. This proves that vital systemic biological secrets are hiding in plain sight in the macroscopic view of standard H&E slides, offering a phenomenal proof-of-concept for global health equity in resource-constrained settingsSupport the showGet the "Digital Pathology 101" FREE E-book and join us!

Featuring perspectives from Dr Stacey A Cohen, Dr Christopher Lieu and Dr Jenny Seligmann, moderated by Dr Lieu, including the following topics: Adjuvant treatment planning for Stage II or III microsatellite instability-high colon cancer (0:00) Roles of circulating tumor DNA (ctDNA), POLE mutations and advanced age in adjuvant treatment planning (6:08) Role of ctDNA in adjuvant treatment planning for Stage III colon cancer (12:31) CME information and select publications

Anne-Marie Dingemans, Isabelle Opiz, and Corinne Faivre-Finn talk about their multidisciplinary efforts to develop a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00051-2/fulltextContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Jay: After a diagnosis of Stage III kidney disease in 2018, I committed to a whole-food, plant-predominant diet, which includes seafood two to three times a week. The results were encouraging, as my kidney function and lipid profile improved dramatically. The switch also resulted in a 25-pound weight loss. When Rondi began intermittent fasting in 2020, I saw her positive results and began eating in an 18-6 or 19-5 window. I lost another 10 pounds and experienced an improvement in my HbA1c; I was no longer pre-diabetic. Three years ago, I transitioned to a one-meal-a-day regimen to get our eating schedules more in synch. Unless dining out with friends, we eat once each day at about 4 pm. My kidney filtration rate and creatinine reading have actually improved, which surprised my primary care doctor at my most recent annual physical. My nephrologist, who is also an IF devotee, took me off high blood pressure medicine six months ago, another very positive step. Intermittent fasting has improved my health in numerous measurable ways, and I will keep this eating pattern for the rest of my life. Rondi: In 2020, after a lifetime of working hard to keep my weight within the normal range, I discovered intermittent fasting. I quickly transitioned into a one-meal-a-day lifestyle. That meal normally consists of seafood, green vegetables, and usually a small dessert. Gradually, over several years, my weight came down to 135 pounds. My heaviest weight was 192, so my total weight loss was 57 pounds. I still have to watch my carb intake. Intermittent fasting changed my life, and I will be an OMAD-er for the rest of my life. Graeme's Links to connect with me directly.Please  Come and Join Our Patreon Community At the Link Belowwww.patreon.com/thefastinghighway.Sign up for a month or stay for a year, check it out, and get all the content. Your first step to excellent support and accountability is right here. I don't know of any hands-on support online for the cost that's as good as our Patreon members' community, and I urge you to check it out. All it's going to cost you is five dollars to access our whole library, including a free copy of my audiobook The Fasting Highway, join our Zoom talk with me directly, and meet other fasters sharing the same wins and struggles as you.To Book a Zoom Call With Graeme One-on-One, Please Go Here www.thefastinghighway.com Click on Get help, get coaching to work with me one-on-one.To Read My Book, The Fasting Highway, go to Amazon or any good book seller. To Listen to My Audio Book Apple Books or many Audio Book Platforms Free on Joining The Patreon Community To be a guest on the show, please go to www.thefastinghighway.com, click on listen to the podcast, and follow the "how to be a guest" prompt.To find everything in one place go to the website www.thefastinghighway.comDisclaimer - All views are those of the host and guest and should not be taken as medical advice. Please consult your doctor before starting any health plan.

Featuring an interview with Dr Christopher Lieu, including the following topics: Historical approach to the adjuvant treatment of localized colorectal cancer (CRC) (0:00) Perspectives on earlier-onset colorectal cancer and potential drivers; management of oligometastatic disease (13:16) Overview of cell-free DNA (circulating tumor DNA [ctDNA]) and techniques for its measurement (17:03) Reliability and prognostic capability of ctDNA as a biomarker for clinical status in patients with localized colorectal cancer (21:10) ctDNA assessment and treatment decision-making for patients with Stage II colon cancer (26:38) Potential incorporation of ctDNA assays into the management of metastatic colorectal cancer or microsatellite instability-high disease (34:29) Available clinical data with ctDNA assessment in localized rectal cancer (38:54) Current practice patterns with ctDNA assays for patients with localized colorectal cancer (41:17) Case: A woman in her early 40s with resected lower risk Stage III colon cancer requests ctDNA testing (45:47) Case: A man in his early 50s with Stage IIIB colon cancer wants to avoid adjuvant chemotherapy (50:39) Case: A man in his early 60s with Stage IV colon cancer receives a positive postoperative ctDNA assessment result (53:24) NCPD information and select publications

Featuring an interview with Dr Stacey A Cohen, Dr Arvind Dasari and Dr Christopher Lieu, including the following topics: Biological Principles Underlying Circulating Tumor DNA (ctDNA) Molecular Residual Disease (MRD) Testing in Colorectal Cancer (CRC) — Dr Cohen (0:00) Potential Utility of ctDNA Testing to Identify Patients with Localized CRC Who Might Benefit from Treatment De-escalation or Escalation — Dr Lieu (17:44) Role of ctDNA Analysis in the Management of Metastatic CRC – Dr Dasari (36:16) Clinical Investigator Survey Results (56:06) Case: A woman in her early 40s with mismatch repair-proficient/microsatellite-stable (MSS), low-risk Stage II colon cancer — Dr Lieu (1:23:05) Case: A woman in her early 70s with microsatellite instability-high Stage III colon cancer with a BRAF mutation — Dr Cohen (1:26:06) Case: A man in his mid 40s with metastatic CRC — Dr Dasari (1:31:57) Case: A man in his early 50s with low-risk Stage III colon cancer — Dr Lieu (1:37:54) Case: A man in his early 30s with MSS, high-risk Stage II CRC — Dr Cohen (1:50:17) Case: A woman in her early 50s with metastatic CRC — Dr Dasari (1:52:05) Case: A man in his early 60s with Stage IV colon cancer — Dr Lieu (1:56:05) CME information and select publications

Join the Behind the Knife Surgical Oncology Team as we discuss the PRADO and NADINA randomized control trials regarding neoadjuvant therapy in Stage III melanoma with macroscopic nodal disease!Hosts:Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center.Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist/HPB surgeon at Kaiser LAMC in Los Angeles.Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a 2ndYear Surgical Oncology fellow at MD Anderson.Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a General Surgery physician in the United States Air Force station at RAF Lakenheath.Joe (Joseph) Broderick, MD, MA (@joebrod5) is a General Surgery research resident between his second and third year at Brooke Army Medical Center.Galen Gist, MD (@gistgalen) is a General Surgery research resident between his second and third year at Brooke Army Medical Center. Learning Objectives:-       Evaluate the role of Completion Lymph Node Dissection (CLND) in patients with positive sentinel lymph nodes, specifically citing the lack of melanoma-specific survival benefit vs. the improvement in regional disease control demonstrated in the MSLT-II trial.-       Determine the appropriate surgical excision margins for primary cutaneous melanoma, comparing the outcomes of 1 cm versus 2 cm margins as analyzed in the MINT trial (Lancet 2019).-       Analyze the impact of adjuvant systemic therapy (Anti-PD1/Immunotherapy) on recurrence-free survival in patients with resected high-risk Stage III melanoma.References:Reijers, I.L.M., Menzies, A.M., van Akkooi, A.C.J. et al. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial. Nat Med 28, 1178–1188 (2022). https://doi.org/10.1038/s41591-022-01851-xChristian U. Blank et al. Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.. J Clin Oncol 42, LBA2-LBA2(2024). DOI:10.1200/JCO.2024.42.17_suppl.LBA2*Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.  Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Featuring an interview with Dr Scott Kopetz, including the following topics:  Circulating tumor DNA (ctDNA)-guided adjuvant chemotherapy de-escalation in the treatment of Stage III colon cancer from the ctDNA-negative cohort of the DYNAMIC-III trial (0:00) Prognostic and predictive role of ctDNA in the management of Stage III colon cancer treated with celecoxib: Findings from the CALGB (Alliance)/SWOG 80702 trial (8:01) Phase III ALTAIR study comparing trifluridine/tipiracil to placebo for patients with molecular residual disease after curative resection of colorectal cancer (CRC); a methylation-based, tissue-free ctDNA test (12:51) ctDNA with locally advanced mismatch repair-deficient/microsatellite instability-high solid tumors; real-world evidence regarding ctDNA with resected CRC (17:31) CME information and select publications

Send us a textFor our 100th episode, we explore how storytelling helps us reclaim body, mind, and spirit after cancer. Gillian Lichota, April Stearns, Melissa Andersen, and Sarah Zsak share how writing transforms fear into agency, supports embodiment, and creates space for healing and connection.Featured book: Rising Above: Our Transformational Journey to Wholeness After Breast CancerGillian Lichota – Founder/CEO of iRise Above Foundation, breast cancer thriver, adventure traveler, and lead author of Rising AboveApril Stearns – Founder/Editor of Wildfire Magazine; breast cancer survivor guiding expressive writing workshops. editor@wildfirecommunity.org IG: @wildfire_bc_magazine FB: facebook.com/wildfirecommunityMelissa Andersen – Former teacher turned nonprofit advocate; HER2+ survivor focused on healing, nature, & creativity. Substack: @melandersen IG: @ms_happyturtle FB: Melissa AndersenSarah Zsak – Speech-language pathologist, mom of four, Peace Corps alum, and Stage III survivor centered in faith, connection & hope. ResourcesPersonal Ink (P.ink Day): https://p-ink.org/p-ink-days/ ACS: Breast Cancer Facts & Figures: https://www.cancer.org/ Ohio State article on early signs of breast cancer: https://cancer.osu.edu/news/most-breast-cancers-dont-start-with-a-noticeable-lump Hopkins Reconstruction Surgeons: Dr. Lily Mundy – https://profiles.hopkinsmedicine.org/provider/lily-mundy/2700651 Dr. Nima Khavanin – https://profiles.hopkinsmedicine.org/provider/nima-khavanin/3052769Support the show Are you loving the Test Those Breasts! Podcast? You can show your support by donating to the Test Those Breasts Nonprofit @ https://testthosebreasts.org/donate/ Where to find Jamie:Instagram LinkedIn TikTok Test Those Breasts Facebook Group LinkTree Jamie Vaughn in the News! Thanks for listening! I would appreciate your rating and review where you listen to podcasts!I am not a doctor and not all information in this podcast comes from qualified healthcare providers, therefore may not constitute medical advice. For personalized medical advice, you should reach out to one of the qualified healthcare providers interviewed on this podcast and/or seek medical advice from your own providers .

Stephanie Marnocha was diagnosed at 33 with Stage III breast cancer. Stephanie is a licensed clinical social worker and outdoors lover. She lives in Denver with her four-legged adventure buddy, Annie. In this episode, Stephanie reads her essay “Being Myself” from the 2024 Body issue of Wildfire Journal. Her piece is about body autonomy and standing by a choice that goes against the grain. April and Stephanie will talk about really seeing yourself when the mastectomy bandages come off, anorexia, losing time to inner dialogues, and insights on keeping a journaling practice. They'll also discuss cancer and fertility.More about episode sponsor After Breast Cancer Diagnosis (ABCD): https://abcdbreastcancersupport.org/Learn more about Stephanie: https://www.facebook.com/stephanie.marnochaPurchase the “Body” issue of Wildfire Journal: https://www.wildfirecommunity.org/shop/p/body24Buy the Wildfire book Igniting the Fire Within: Stories of Healing, Hope & Humor, Inside Today's Young Breast Cancer Community: https://www.amazon.com/dp/B0BJVJ629F?ref_=pe_3052080_397514860Get the free Wildfire “Hot Flashes” email newsletter: https://www.wildfirecommunity.org/newsletter?rq=newsletterLearn about Wildfire writing workshops: https://www.wildfirecommunity.org/workshopsShop Wildfire merch & more: https://www.wildfirecommunity.org/shop*Free* Get Wildfire and The Burn freebies here: https://www.wildfirecommunity.org/freeMore about Wildfire Journal: https://www.wildfirecommunity.orghttps://www.instagram.com/wildfire_bc_magazine/https://www.facebook.com/wildfirecommunityInformation on submitting your story for consideration to be published in Wildfire Journal: https://www.wildfirecommunity.org/submissions

Show notes and links: https://www.chrisbeatcancer.com/50-years-cancer-free-how-rick-hill-healed-stage-iii-naturally/

Featuring an interview from Dr John Strickler, including the following topics: Prognostic value of molecular residual disease (MRD) as detected by circulating tumor DNA (ctDNA) and optimal incorporation of MRD assays into the care of patients with colorectal cancer (0:00) Potential use of MRD assays for patients with microsatellite instability (MSI)-high localized colorectal cancer or those with delayed progression or metastatic disease (16:09) Tumor-informed MRD assays under clinical development (20:36) Predictive role of ctDNA in Stage III colon cancer treated with celecoxib; effect of low-dose aspirin on response to celecoxib in patients with PI3K pathway alterations (24:19) Case: A man in his late 50s with resected Stage IIA colon cancer (30:06) Case: A woman in her late 40s with Lynch syndrome and MSI-H colon cancer with a solitary, small hepatic metastasis (34:57) MRD as a future clinical trial endpoint for solid tumors; increasing incidence of colorectal cancer in younger people (40:24) Antibody-drug conjugates in the treatment of colorectal cancer (45:13) Perspectives on promising areas of clinical research in colorectal cancer (48:23) CME information and select publications

Featuring a slide presentation and related discussion from Dr John Strickler, including the following topics: Defining molecular residual disease (MRD); tumor-informed and tumor-naïve methods for assessing (0:00) GALAXY and BESPOKE CRC studies of a tumor-informed MRD assay to identify patients with localized colorectal cancer who have an increased risk of recurrence and those who are likely to benefit from adjuvant chemotherapy (6:56) Sustained circulating tumor DNA (ctDNA) clearance and disease-free survival outcomes for patients with localized colorectal cancer (13:21) DYNAMIC study of a ctDNA-guided approach to adjuvant chemotherapy for patients with Stage II colorectal cancer (16:17) ctDNA positivity and radiographic evidence of colorectal cancer (18:48) ctDNA-guided approaches to escalating or de-escalating adjuvant chemotherapy for patients with localized colorectal cancer (21:24) Predictive role of ctDNA assay results in Stage III colon cancer treated with celecoxib; low-dose aspirin for patients with Stage II to III colorectal cancer with a PI3K pathway alteration (26:02) CME information and select publications

Shannon Gottesman was diagnosed at age 40 with hormone positive, Stage III breast cancer. She is the Vice Chancellor at the University of Pittsburgh, a traveler, an advocate, and mom of two boys. In this episode, Shannon reads her essay “On This Mat” from the 2024 “Body” issue of Wildfire Journal. Her piece is about learning to breathe through discomfort while finding balance in chaos, and to honor a body that has fought so hard to endure. April and Shannon will discuss the complexities of cancerversaries, bridging the mind and body through yoga, mantras, and taking pause in life.More about Shannon: https://www.instagram.com/shanny5159/Purchase the “Body” issue of Wildfire Journal: https://www.wildfirecommunity.org/shop/p/body24Buy the Wildfire book Igniting the Fire Within: Stories of Healing, Hope & Humor, Inside Today's Young Breast Cancer Community: https://www.amazon.com/dp/B0BJVJ629F?ref_=pe_3052080_397514860Get the free Wildfire “Hot Flashes” email newsletter: https://www.wildfirecommunity.org/newsletter?rq=newsletterLearn about Wildfire writing workshops: https://www.wildfirecommunity.org/workshopsShop Wildfire merch & more: https://www.wildfirecommunity.org/shop*Free* Get Wildfire and The Burn freebies here: https://www.wildfirecommunity.org/freeMore about Wildfire Journal: https://www.wildfirecommunity.orghttps://www.instagram.com/wildfire_bc_magazine/https://www.facebook.com/wildfirecommunityInformation on submitting your story for consideration to be published in Wildfire Journal: https://www.wildfirecommunity.org/submissions

After facing a life-changing cancer diagnosis, Diane Simard realized survivorship didn't come with a script that fit. So she wrote her own. In this episode of Your Next Business Bestie, Diane shares her journey as a Stage III breast cancer survivor, business executive, author, and unapologetic disruptor of the pink ribbon narrative. We talk about the emotional side of survivorship that often gets overlooked, the power of being misunderstood, and how Diane found healing through writing, advocacy, and boldly sharing her truth. She opens up about founding the Center for Oncology Psychology Excellence (COPE), navigating grief, and why she's so committed to speaking up for the ones who can't. If you've ever felt boxed in by labels or like your story doesn't match what people expect, this one's for you.

LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania by IASLC

CME credits: 1.00 Valid until: 31-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iiiiv-melanoma/36325/ This online CME activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN®), focuses on translating oncology clinical practice guidelines into practical strategies for treating melanoma. Participants will learn how to integrate clinical trial data into guideline-concordant treatment plans in the neoadjuvant, adjuvant, and metastatic settings. The program highlights the importance of evidence-based approaches and the use of immunotherapy for the treatment of melanoma. Attendees will also explore emerging data that could influence future treatment guidelines, patient case examples, and insights from international faculty to develop region-specific therapeutic tactics aligned with NCCN Guideline® recommendations. *This program was published on July 31st, 2025 and the information therein was up-to-date when created.

CME credits: 1.00 Valid until: 31-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/implementing-guideline-concordant-care-for-a-patient-with-newly-diagnosed-stage-iii-melanoma/36326/ This online CME activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN®), focuses on translating oncology clinical practice guidelines into practical strategies for treating melanoma. Participants will learn how to integrate clinical trial data into guideline-concordant treatment plans in the neoadjuvant, adjuvant, and metastatic settings. The program highlights the importance of evidence-based approaches and the use of immunotherapy for the treatment of melanoma. Attendees will also explore emerging data that could influence future treatment guidelines, patient case examples, and insights from international faculty to develop region-specific therapeutic tactics aligned with NCCN Guideline® recommendations. *This program was published on July 31st, 2025 and the information therein was up-to-date when created.

CME credits: 1.00 Valid until: 31-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iiiiv-melanoma/36325/ This online CME activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN®), focuses on translating oncology clinical practice guidelines into practical strategies for treating melanoma. Participants will learn how to integrate clinical trial data into guideline-concordant treatment plans in the neoadjuvant, adjuvant, and metastatic settings. The program highlights the importance of evidence-based approaches and the use of immunotherapy for the treatment of melanoma. Attendees will also explore emerging data that could influence future treatment guidelines, patient case examples, and insights from international faculty to develop region-specific therapeutic tactics aligned with NCCN Guideline® recommendations. *This program was published on July 31st, 2025 and the information therein was up-to-date when created.

CME credits: 1.00 Valid until: 31-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/implementing-guideline-concordant-care-for-a-patient-with-newly-diagnosed-stage-iii-melanoma/36326/ This online CME activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN®), focuses on translating oncology clinical practice guidelines into practical strategies for treating melanoma. Participants will learn how to integrate clinical trial data into guideline-concordant treatment plans in the neoadjuvant, adjuvant, and metastatic settings. The program highlights the importance of evidence-based approaches and the use of immunotherapy for the treatment of melanoma. Attendees will also explore emerging data that could influence future treatment guidelines, patient case examples, and insights from international faculty to develop region-specific therapeutic tactics aligned with NCCN Guideline® recommendations. *This program was published on July 31st, 2025 and the information therein was up-to-date when created.

Gillian Lichota was diagnosed at 35 and 40—first with Stage III and later with Stage IV breast cancer. She is a mother, mountain climber, adventure travel enthusiast, and the Founder and CEO of the iRise Above Foundation, a nonprofit organization dedicated to empowering and supporting young women through breast cancer. In this episode, Gillian reads her essay “An Open Letter to My Daughter, Layke” from the 2024 “Mothers & Daughters” issue of Wildfire Journal. Her piece is about the ways motherhood transforms us. April and Gillian will discuss the healing found in witnessing your child's life, leading your children with intention, the legacy offerings we want for our children,and modeling vulnerability. They will also discuss Gillian's careers from marine biologist to founder of a non-profit breast cancer organization. More about Gillian:https://www.iriseabovefoundation.org/https://www.instagram.com/irise_abovehttps://www.instagram.com/irise_abovehttps://www.facebook.com/iRiseAboveFoundationhttps://www.youtube.com/channel/UCf8r9NWe1TzJ77m2_zeeLtAPurchase the “Mothers & Daughters” issue of Wildfire Journal: https://www.wildfirecommunity.org/shop/p/mothers24Buy the Wildfire book Igniting the Fire Within: Stories of Healing, Hope & Humor, Inside Today's Young Breast Cancer Community: https://www.amazon.com/dp/B0BJVJ629F?ref_=pe_3052080_397514860Get the free Wildfire “Hot Flashes” email newsletter: https://www.wildfirecommunity.org/newsletter?rq=newsletterLearn about Wildfire writing workshops: https://www.wildfirecommunity.org/workshopsShop Wildfire merch & more: https://www.wildfirecommunity.org/shop*Free* Get Wildfire and The Burn freebies here: https://www.wildfirecommunity.org/freeMore about Wildfire Journal: https://www.wildfirecommunity.orghttps://www.instagram.com/wildfire_bc_magazine/https://www.facebook.com/wildfirecommunityInformation on submitting your story for consideration to be published in Wildfire Journal: https://www.wildfirecommunity.org/submissions

Today, we reflect on the life and legacy of Ananda Lewis, the influential MTV VJ and talk show host who has passed away at 52. From her early days on 'Teen Summit' to becoming a defining face of MTV's 'Total Request Live' and 'Hot Zone,' Lewis captivated audiences with her intelligence and charisma. In 2020, she bravely opened up about her Stage III breast cancer diagnosis, advocating for prevention and transparent discussions around treatment. A proud graduate of Howard University, Ananda Lewis leaves behind a significant cultural impact and a beloved son, Langston. Join us as we honor her memory. Subscribe to our newsletter to stay informed with the latest news from a leading Black-owned & controlled media company: https://aurn.com/newsletter Learn more about your ad choices. Visit megaphone.fm/adchoices

Today, we reflect on the life and legacy of Ananda Lewis, the influential MTV VJ and talk show host who has passed away at 52. From her early days on 'Teen Summit' to becoming a defining face of MTV's 'Total Request Live' and 'Hot Zone,' Lewis captivated audiences with her intelligence and charisma. In 2020, she bravely opened up about her Stage III breast cancer diagnosis, advocating for prevention and transparent discussions around treatment. A proud graduate of Howard University, Ananda Lewis leaves behind a significant cultural impact and a beloved son, Langston. Join us as we honor her memory. Subscribe to our newsletter to stay informed with the latest news from a leading Black-owned & controlled media company: https://aurn.com/newsletter Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of Clocking Out, we meet Haley Pollack — a former academic and educator whose life took a dramatic turn when she was diagnosed with Stage III colon cancer at age 37. A mother of two, including a six-month-old at the time, Haley found herself navigating not only a devastating diagnosis but also the emotional complexity of parenting through it.Haley's career began in academia, with a PhD in U.S. history and a deep passion for teaching. After a decade in the adjunct “rat race,” she left higher education to work at the intersection of criminal justice and education, teaching English and literature to incarcerated students at San Quentin. The work was humbling, eye-opening, and deeply transformative. It challenged her assumptions, expanded her empathy, and reminded her of the power of education to change lives. It was some of the most meaningful work of her life — until illness steered her toward a different mission.Her diagnosis left her searching for support — not just as a patient, but as a parent. That search led to a transformative friendship and, ultimately, the founding of Bright Spot Network, a nonprofit that supports young families navigating a parent's cancer diagnosis. Today, Bright Spot serves thousands of families each year through peer support groups, parenting resources, financial assistance, and community-building tools.Haley shares how her personal crisis reshaped her professional purpose, why she believes connection is key to healing, and how her work is bringing light to others in their darkest moments. Her story is a powerful reminder that even in hardship, we can build something hopeful — for ourselves and for others.Connect with Haley at:Website: http://www.brightspotnetwork.org/Instagram: @brightspotnetworkFacebook: @brightspotnetworkLinkedIn: Bright Spot NetworkLinkedIn: Haley PollackFollow Raymond: LinkedIn: Raymond LeeInstagram: @raymondlee.coTiktok: @clockingoutpodX: @hrentrepreneurYoutube: @clockingoutwithraymondleeClick Here to become a guest on Clocking Out

Colon cancer runs in my family. Between that and having ulcerative colitis (that is now in remission) I get a colonoscopy every couple years. By 2030, colon cancer is predicted to be the top cancer death for people younger than 50. That's why it's important to get your cancer screenings when they are recommended. And this year, it is Penn's turn to get his check-up. (That's right, we're talking all about butt stuff.) We take you along for the prep, process, and results, as well as chat with Stage III colon cancer survivor and entrepreneur, Brooks Bell. Brooks is on a mission to raise awareness for colon cancer, normalize colonoscopies, and make colon cancer screenings more accessible through her clothing company, Worldclass. While we always try to take a light-hearted approach to everything we do, cancer is serious. Learn more about cancer prevention and how you can help. Shop Worldclass ClothingLearn More About Colon CancerVisit Our ShopJoin Our NewsletterFind us on SubstackFollow us on YouTubeFollow us on InstagramFollow us on TikTok Follow us on FacebookKim and Penn are award-winning content creators known for their online videos, including original music, song parodies, and comedy sketches. Their videos have resulted in over 2 billion views and 9 million followers across their social media platforms since they (accidentally) went viral in 2013. They have a New York Times bestselling book on ADHD, best-selling book on marriage communication, a top-rated podcast, a fun-filled family card game, and most recently, they were the winners on Season 33 of The Amazing Race.The Holderness Family Podcast is produced by Ann Marie Taepke and edited and engineered by Max Trujillo of Trujillo Media and Sam Allen. Hosted on Acast. See acast.com/privacy for more information.

Virtual Tumor Board: Stage III ALK+ NSCLC by IASLC

This episode's guest is Wildfire's own Angela Firman - back for a second visit! She helps edit each issue of the magazine. Angela was diagnosed initially at 33 with Stage III hormone-positive breast cancer and she is now living with Stage IV metastatic disease. Angela is an avid reader, a closet-cross-stitcher, and a fervent writer. She also serves on the board of The Pink Boat Regatta - a local sailboat race and community dedicated to raising money for breast cancer research. In addition to working at Wildfire Magazine, Angela is an Associate Editor for Yellow Arrow Publishing, and her nonfiction writing has been published in Open Minds Quarterly, You Might Need To Hear This, and Press Pause. Angela reads her piece “A Train to Nowhere” from Wildfire Magazine's 2024 “Work & Career” issue. Her essay is about how sometimes cancer significantly changes a career path. April and Angela will discuss writing memoir in the third person, when suffering brings joy and living with MBC versus dying from MBC.More about Angela: https://www.instagram.com/angelafirman11/More about After Breast Cancer Diagnosis (ABCD):https://abcdbreastcancersupport.org/https://www.instagram.com/abcdafterbreastcancerdiagnosis/https://www.facebook.com/ABCDAfterBreastCancerDiagnosis/?ref=tshttps://www.youtube.com/channel/UCY4VHSTPyU1IYyT1fNesmAgPurchase the “Work & Career” issue of Wildfire Magazine: https://www.wildfirecommunity.org/shop/p/digital-body24If you liked this episode, you might like “Looking Beyond the Veil with Angela Firman, too: https://player.captivate.fm/episode/7630add0-ded8-43c0-9ad5-cacad940fd5b/Buy the Wildfire book Igniting the Fire Within: Stories of Healing, Hope & Humor, Inside Today's Young Breast Cancer Community: https://www.amazon.com/dp/B0BJVJ629F?ref_=pe_3052080_397514860Get the free Wildfire “Hot Flashes” email newsletter: https://www.wildfirecommunity.org/newsletter?rq=newsletterLearn about Wildfire writing workshops: https://www.wildfirecommunity.org/workshopsShop Wildfire merch & more: https://www.wildfirecommunity.org/shop*Free* Get Wildfire and The Burn freebies here: https://www.wildfirecommunity.org/freeMore about Wildfire Magazine: https://www.wildfirecommunity.orghttps://www.instagram.com/wildfire_bc_magazine/

Early on, it's easy to think you're a failure at meditation. Truth is, you're probably not. Try easing the patterns that just hold you back.About Sebene Selassie:Growing up, Sebene felt like a big weirdo. Born in Addis Ababa, Ethiopia and raised in white neighborhoods in Washington, D.C., she was a tomboy Black girl who loved Monty Python and UB40. She never believed she belonged. Thirty years ago, she began studying Buddhism as an undergraduate at McGill University where she majored in Comparative Religious Studies. Now, Sebene is a teacher, author, and speaker who teaches that meditation can help us remember our inherent sense of belonging, that our individual freedom affects absolutely everyone and everything, and that our collective freedom depends on each and every one of us. Sebene is a three-time cancer survivor of Stage III and IV cancer.To find this meditation in the Happier Meditation app, you can search for “Criticizing Your Meditation.”See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week we're sharing a favorite episode from the archives as we take a break from our regular podcast schedule to celebrate the New Year. Production assistant Monica Haro selected this episode from December 2021 to reshare. Enjoy!Tova Wolking is an attorney from Oakland, California. She was diagnosed at age 43 with Stage III, hormone positive breast cancer. She also carries the BRCA2 gene. In this episode, Tova reads her piece “Swim” from Wildfire Magazine's 2021 “Bay Area Young Survivors” issue. In the wake of Tova's mom passing away, breast cancer took root in her body. This is the story of one woman asking how to find the key to unlocking her own grief about her breast cancer when her mother took so many of those answers with her when she died. Note of warning for sensitive listeners, this episode touches upon loss and suicide. More about Bay Area Young Survivors: https://bayareayoungsurvivors.org/members/Get the “Bay Area Young Survivors” issue here: https://www.wildfirecommunity.org/shop/p/digital-bays21Buy the Wildfire book Igniting the Fire Within: Stories of Healing, Hope & Humor, Inside Today's Young Breast Cancer Community: https://www.amazon.com/dp/B0BJVJ629F?ref_=pe_3052080_397514860Get the free Wildfire “Hot Flashes” email newsletter: https://www.wildfirecommunity.org/newsletter?rq=newsletterLearn about Wildfire writing workshops: https://www.wildfirecommunity.org/workshopsShop Wildfire merch & more: https://www.wildfirecommunity.org/shop*Free* Get Wildfire and The Burn freebies here: https://www.wildfirecommunity.org/freeMore about Wildfire Magazine: https://www.wildfirecommunity.orghttps://www.instagram.com/wildfire_bc_magazine/https://www.facebook.com/wildfirecommunityInformation on submitting your story for consideration to be published in Wildfire Magazine: https://www.wildfirecommunity.org/submissions

Claire Lemiski is an airline pilot who was diagnosed at 36 with Stage III, hormone positive breast cancer. As a captain at a regional airline in Toronto, Claire is passionate about providing mentorship to new and aspiring women pilots. In this episode, Claire reads her essay “About Damn Time” from Wildfire Magazine's 2024 “Family” issue. Claire's piece is about breast cancer being a genderless disease, and a bond that was strengthened with her father because of their shared experience of both receiving a breast cancer diagnosis. April and Claire will discuss using a musical container for writing, the treatment contrasts and misconceptions of male breast cancer, reconstruction, and the intersection of career and cancer. They will also talk about Claire's lymphedema concerns, and when it's appropriate to talk about breast cancer when asked about her lymphedema compression sleeve.More about Claire: https://www.instagram.com/flatpilot/Purchase the “Family” issue of Wildfire Magazine: https://www.wildfirecommunity.org/shop/p/family24Buy the Wildfire book Igniting the Fire Within: Stories of Healing, Hope & Humor, Inside Today's Young Breast Cancer Community: https://www.amazon.com/dp/B0BJVJ629F?ref_=pe_3052080_397514860Get the free Wildfire “Hot Flashes” email newsletter: https://www.wildfirecommunity.org/newsletter?rq=newsletterLearn about Wildfire writing workshops: https://www.wildfirecommunity.org/workshopsShop Wildfire merch & more: https://www.wildfirecommunity.org/shop*Free* Get Wildfire and The Burn freebies here: https://www.wildfirecommunity.org/freeMore about Wildfire Magazine: https://www.wildfirecommunity.orghttps://www.instagram.com/wildfire_bc_magazine/https://www.facebook.com/wildfirecommunityInformation on submitting your story for consideration to be published in Wildfire Magazine: https://www.wildfirecommunity.org/submissions

This episode of The Forbes Factor brings you two incredible women who turned life's toughest challenges into platforms for empowerment. Forbes Riley sits down with Heather Monahan, a confidence coach and bestselling author, and Barbara Majeski, a lifestyle expert and cancer survivor, for a conversation that will leave you inspired and ready to take action. Heather shares how she climbed the corporate ladder, faced setbacks, and became a sought-after speaker and author, inspiring thousands to build unshakeable confidence. Barbara reveals how surviving Stage III colon cancer transformed her life and led her to become the “Curator of the Good Life.” Together, they discuss overcoming self-doubt, building resilience, and creating a life of impact and authenticity. You'll learn actionable strategies for staying motivated, creating your personal roadmap for success, and living a life filled with purpose, confidence, and style. This episode is packed with heartfelt stories, bold advice, and the energy you need to tackle any challenge.

Unraveling one of our main sources of unhappiness.About Sebene Selassie:Growing up, Sebene felt like a big weirdo. Born in Addis Ababa, Ethiopia and raised in white neighborhoods in Washington, D.C., she was a tomboy Black girl who loved Monty Python and UB40. She never believed she belonged. Thirty years ago, she began studying Buddhism as an undergraduate at McGill University where she majored in Comparative Religious Studies. Now, Sebene is a teacher, author, and speaker who teaches that meditation can help us remember our inherent sense of belonging, that our individual freedom affects absolutely everyone and everything, and that our collective freedom depends on each and every one of us. Sebene is a three-time cancer survivor of Stage III and IV cancer.Check out Sebene's Substack newsletter, Ancestors to Elements. To find this meditation in the Happier app, you can search for “Hope in the Everyday.”See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The grind never stops here as Topher calls in from Calgary and joins Jeff to discuss the six C's of hockey development. There are six traits players should have to succeed. Listen as we dive into the first three of six. Don't miss part two coming soon! In this episode we talk about: — Creativity — Competitiveness — Coachability AND SO MUCH MORE! Please consider donating to support Kelly Deschamps in her battle against Stage III breast cancer: Kelly's Cross Donation Thank you to our title sponsor IceHockeySystems.com, as well as Train-Heroic, CuredNutrition, Helios Hockey, and Crossbar!  And thank you to our AMAZING LISTENERS; We appreciate every listen, download, comment, rating and share on your social sites! If you'd like to join our Hockey Think Tank Community, head over to Community.TheHockeyThinkTank.com and check it out! Follow us: IG: @HockeyThinkTank X (Twitter): @HockeyThinkTank TikTok: @HockeyThinkTank Facebook: TheHockeyThinkTank

Drs Armstrong and Tawagi discuss the NADINA trial of neoadjuvant nivolumab/ipilimumab vs adjuvant nivolumab in resectable, macroscopic, stage III melanoma.

This week's episode will be discussing updates from ASCO 2024 next with the practice changing NADINA trial presented on the Sunday of ASCO by Dr. Christian Blank during the plenary sessions:  A multicenter, randomized, phase 3 trial comparing the efficacy of neoadjuvant ipilimumab plus nivolumab with standard adjuvant nivolumab in macroscopic resectable stage III melanoma. We discuss the staging and prior standard of treatment for locally advanced melanoma, key findings from NADINA, and how these data may impact clinical practice.

When you're spiraling with intense emotions, here's a practice to help pick you up off the bathroom floor. About Sebene Selassie:Growing up, Sebene felt like a big weirdo. Born in Addis Ababa, Ethiopia and raised in white neighborhoods in Washington, D.C., she was a tomboy Black girl who loved Monty Python and UB40. She never believed she belonged. Thirty years ago, she began studying Buddhism as an undergraduate at McGill University where she majored in Comparative Religious Studies. Now, Sebene is a teacher, author, and speaker who teaches that meditation can help us remember our inherent sense of belonging, that our individual freedom affects absolutely everyone and everything, and that our collective freedom depends on each and every one of us. Sebene is a three-time cancer survivor of Stage III and IV cancer.To find this meditation in the Ten Percent Happier app, you can search for “Meltdown.”See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode we welcome returning guest Emma Jarrett back to The Burn for a second visit. She is a performance coach and writer who was diagnosed at 51 with Stage III, triple positive, invasive lobular breast cancer. Emma reads her essay “Paper Aeroplane” from the 2024 “Family” issue of Wildfire Magazine. Emma's piece is about not being able to parent her young children the way she is accustomed during her cancer treatment. April and Emma will talk about parenting and communicating differently with our children after a cancer diagnosis, the role of writing in parenting, and the minimization of being told your breasts have done their job when losing them. Emma will also share her advice on writing about cancer.Connect with Emma:https://www.instagram.com/emmajarrettwrites/https://www.instagram.com/emmajbreastless/https://emmajarrett.substack.com/https://emmajarrett.ca/Purchase the “Family” issue here: https://www.wildfirecommunity.org/shop/p/family24Listen to another episode featuring Emma: https://player.captivate.fm/episode/ef401f5e-553d-4fac-bb98-a646e3e5c42fBuy the Wildfire book Igniting the Fire Within: Stories of Healing, Hope & Humor, Inside Today's Young Breast Cancer Community: https://www.amazon.com/dp/B0BJVJ629F?ref_=pe_3052080_397514860Get the free Wildfire “Hot Flashes” email newsletter: https://www.wildfirecommunity.org/newsletter?rq=newsletterLearn about Wildfire writing workshops: https://www.wildfirecommunity.org/workshopsShop Wildfire merch & more: https://www.wildfirecommunity.org/shop*Free* Get Wildfire and The Burn freebies here: https://www.wildfirecommunity.org/freeMore about Wildfire Magazine: https://www.wildfirecommunity.orghttps://www.instagram.com/wildfire_bc_magazine/https://www.facebook.com/wildfirecommunityInformation on submitting your story for consideration to be published in Wildfire Magazine: https://www.wildfirecommunity.org/submissions

Diagnosed with with Stage III Colon Cancer at just 27 years old, Nicole shares how her diagnosis actually fortified her faith. After sharing a video of her story, it quickly rose to over 23.4 million views with others sharing their stories and the goodness of God despite life's trials.If your faith needs fortifying, this episode is for you!Books Mentioned:Chris Beat Cancerhttps://www.amazon.com/dp/1401956130/ref=cm_sw_r_as_gl_api_gl_i_6SDT32SSCT5CGP348JK2?linkCode=ml2&tag=addiewoost-20It's Not Supposed to Be This Way: Finding Unexpected Strength When Disappointments Leave You Shattered by Lisa TerKeursthttps://www.amazon.com/dp/0718039858/ref=cm_sw_r_as_gl_api_gl_i_29KXW9J8CRK34QMKV2FM?linkCode=ml2&tag=addiewoost-20Nicole's Instagramhttps://www.instagram.com/nicoleellasmith/Addie's Socials   YouTube TikTok Instagram LINKS Elevated Faith Apparel LikeToKnowIt Amazon Storefront Support the Show.

Check out this week's QuadCast as we highlight major findings from ASCO 2024! Learn about immunotherapy neoadjuvantly for Stage III melanoma, the role of osimertinib in localized NSCLC, the role of short vs. long course ADT in salvage prostate treatment, and much more. Check out the website and subscribe to the newsletter! www.quadshotnews.com Founders & Lead Authors: Laura Dover & Caleb Dulaney Podcast Host: Sam Marcrom

This week, we kick off our discussion of adjuvant systemic treatment in colon cancer, beginning with Stage III colon cancer. We will review the evidence basis for adjuvant therapy as well as the two main chemotherapy regimens including duration and side effects. Content: - Why do we need adjuvant therapy in stage III colon cancer? - What is FOLFOX? What is CAPOX? When do we use what?- What is the optimal duration of therapy? - What are the characteristics deemed high risk? - Can we discontinue oxaliplatin early? - What is the role of oxaliplatin in older patients? ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

New episodes come out every Monday, Wednesday, and Friday for free, with 1-week early access for Wondery+ subscribers.---Get comfortable with uncertainty and cultivate trust in life, even in the most turbulent times.About Sebene Selassie:Growing up, Sebene felt like a big weirdo. Born in Addis Ababa, Ethiopia and raised in white neighborhoods in Washington, D.C., she was a tomboy Black girl who loved Monty Python and UB40. She never believed she belonged. Thirty years ago, she began studying Buddhism as an undergraduate at McGill University where she majored in Comparative Religious Studies. Now, Sebene is a teacher, author, and speaker who teaches that meditation can help us remember our inherent sense of belonging, that our individual freedom affects absolutely everyone and everything, and that our collective freedom depends on each and every one of us. Sebene is a three-time cancer survivor of Stage III and IV cancer.To find this meditation in the Ten Percent Happier app, you can search for “Trust Yourself and Breathe.”See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

E396 Kineret Sherman was forty-three when she was diagnosed with Stage II rectal cancer. After holistic options failed and became Stage III, she opted for more traditional options, but no one told her about the toll it would take on her – more specifically, how she would need to adjust as a sexual being. She […]

Find freedom from obsessive loops of fear by getting grounded in the body, dropping the stories, and bringing some kindness to the struggle.About Sebene Selassie:Growing up, Sebene felt like a big weirdo. Born in Addis Ababa, Ethiopia and raised in white neighborhoods in Washington, D.C., she was a tomboy Black girl who loved Monty Python and UB40. She never believed she belonged. Thirty years ago, she began studying Buddhism as an undergraduate at McGill University where she majored in Comparative Religious Studies. Now, Sebene is a teacher, author, and speaker who teaches that meditation can help us remember our inherent sense of belonging, that our individual freedom affects absolutely everyone and everything, and that our collective freedom depends on each and every one of us. Sebene is a three-time cancer survivor of Stage III and IV cancer.To find this meditation in the Ten Percent Happier app, you can search for “Loosening the Grip of Panic.”See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this gentle meditation, Sebene offers support for grief. She guides you through a practice of kindness and compassion for yourself.About Sebene Selassie:Growing up, Sebene felt like a big weirdo. Born in Addis Ababa, Ethiopia and raised in white neighborhoods in Washington, D.C., she was a tomboy Black girl who loved Monty Python and UB40. She never believed she belonged. Thirty years ago, she began studying Buddhism as an undergraduate at McGill University where she majored in Comparative Religious Studies. Now, Sebene is a teacher, author, and speaker who teaches that meditation can help us remember our inherent sense of belonging, that our individual freedom affects absolutely everyone and everything, and that our collective freedom depends on each and every one of us. Sebene is a three-time cancer survivor of Stage III and IV cancer.To find this meditation in the Ten Percent Happier app, you can search for “Working with Grief.” You can hear Sebene, along with teacher Jeff Warren, on the Meditation Party episodes:#553. Meditation Party: The Sh*t Is Fertilizer Edition#601: Meditation Party: Psychedelics, ADHD, Waking Up from Distraction, and Singing Without Being Self-ConsciousMore info on the upcoming Omega Institute Retreat (available in-person and virtually) with Dan, Sebene, and Jeff is here. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Working through fear by anchoring in the breath and body gives you the capacity to be fully available to help when help is needed.About Sebene Selassie:Growing up, Sebene felt like a big weirdo. Born in Addis Ababa, Ethiopia and raised in white neighborhoods in Washington, D.C., she was a tomboy Black girl who loved Monty Python and UB40. She never believed she belonged. Thirty years ago, she began studying Buddhism as an undergraduate at McGill University where she majored in Comparative Religious Studies. Now, Sebene is a teacher, author, and speaker who teaches that meditation can help us remember our inherent sense of belonging, that our individual freedom affects absolutely everyone and everything, and that our collective freedom depends on each and every one of us. Sebene is a three-time cancer survivor of Stage III and IV cancer.To find this meditation in the Ten Percent Happier app, you can search for “Caring for Vulnerable People,” or click here: https://10percenthappier.app.link/content?meditation=bc7cb7bc-6883-466f-8626-cad27be2a5e6See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.